The prescribing information explicitly states the starting dose is not effective for glycemic control and then instructs escalation after 30 days (FDA label (PDF))
Wegovy is FDA-approved for supporting weight loss in individuals who meet one of the following criteria: Have obesity, defined as a body mass index (BMI) of 30 kg/m or higher, or
Retatrutide is an investigational peptide studied for weight loss, glucose regulation, and metabolic health
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring peptide known for promoting deep, restorative sleep
A commonly prescribed oral medication is Rybelsus (semaglutide), which is taken daily rather than weekly like injectable options
Perhaps most intriguingly for menopausal women concerned about metabolic health, tesamorelin also reduced hepatic (liver) fat by 37 percent